Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH AUROBINDO PHARMA PROCTER & GAMBLE HEALTH/
AUROBINDO PHARMA
 
P/E (TTM) x 35.7 21.1 169.2% View Chart
P/BV x 10.9 2.2 498.5% View Chart
Dividend Yield % 2.0 0.3 650.0%  

Financials

 PROCTER & GAMBLE HEALTH   AUROBINDO PHARMA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
AUROBINDO PHARMA
Mar-23
PROCTER & GAMBLE HEALTH/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs5,366715 750.9%   
Low Rs3,883397 977.3%   
Sales per share (Unadj.) Rs740.7424.2 174.6%  
Earnings per share (Unadj.) Rs138.232.9 420.2%  
Cash flow per share (Unadj.) Rs155.254.1 286.6%  
Dividends per share (Unadj.) Rs95.003.00 3,166.7%  
Avg Dividend yield %2.10.5 380.7%  
Book value per share (Unadj.) Rs447.6458.1 97.7%  
Shares outstanding (eoy) m16.60585.94 2.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.21.3 476.3%   
Avg P/E ratio x33.516.9 197.9%  
P/CF ratio (eoy) x29.810.3 290.2%  
Price / Book Value ratio x10.31.2 851.2%  
Dividend payout %68.79.1 753.6%   
Avg Mkt Cap Rs m76,761325,753 23.6%   
No. of employees `000NANA-   
Total wages/salary Rs m2,06235,223 5.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,296248,554 4.9%  
Other income Rs m1842,906 6.3%   
Total revenues Rs m12,480251,460 5.0%   
Gross profit Rs m3,24737,070 8.8%  
Depreciation Rs m28112,446 2.3%   
Interest Rs m81,405 0.5%   
Profit before tax Rs m3,14226,125 12.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8476,849 12.4%   
Profit after tax Rs m2,29519,277 11.9%  
Gross profit margin %26.414.9 177.0%  
Effective tax rate %27.026.2 102.9%   
Net profit margin %18.77.8 240.6%  
BALANCE SHEET DATA
Current assets Rs m11,713214,599 5.5%   
Current liabilities Rs m6,791114,938 5.9%   
Net working cap to sales %40.040.1 99.8%  
Current ratio x1.71.9 92.4%  
Inventory Days Days26321 1,274.4%  
Debtors Days Days34366 523.7%  
Net fixed assets Rs m10,617176,668 6.0%   
Share capital Rs m166586 28.3%   
"Free" reserves Rs m7,265267,813 2.7%   
Net worth Rs m7,431268,399 2.8%   
Long term debt Rs m06,190 0.0%   
Total assets Rs m22,330392,125 5.7%  
Interest coverage x409.119.6 2,087.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.6 86.9%   
Return on assets %10.35.3 195.5%  
Return on equity %30.97.2 430.0%  
Return on capital %42.410.0 422.8%  
Exports to sales %033.7 0.0%   
Imports to sales %13.115.3 85.3%   
Exports (fob) Rs mNA83,703 0.0%   
Imports (cif) Rs m1,60538,060 4.2%   
Fx inflow Rs m1,46585,483 1.7%   
Fx outflow Rs m1,60541,447 3.9%   
Net fx Rs m-14044,036 -0.3%   
CASH FLOW
From Operations Rs m2,36023,868 9.9%  
From Investments Rs m-215-39,778 0.5%  
From Financial Activity Rs m-98518,144 -5.4%  
Net Cashflow Rs m1,1602,298 50.5%  

Share Holding

Indian Promoters % 0.0 48.8 -  
Foreign collaborators % 51.8 3.1 1,687.9%  
Indian inst/Mut Fund % 20.3 41.3 49.0%  
FIIs % 7.6 20.7 36.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 48.2 100.0%  
Shareholders   56,730 241,944 23.4%  
Pledged promoter(s) holding % 0.0 20.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Procter & Gamble Health vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs Aurobindo Pharma Share Price Performance

Period Procter & Gamble Health Aurobindo Pharma S&P BSE HEALTHCARE
1-Day -0.40% -1.75% -1.03%
1-Month -3.20% -3.93% -5.08%
1-Year -0.96% 110.79% 57.36%
3-Year CAGR -8.88% 6.68% 18.12%
5-Year CAGR 8.01% 5.15% 18.86%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

Aurobindo Pharma paid Rs 3.0, and its dividend payout ratio stood at 9.1%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.